ARCHIVES

In Brief: Three Centers Win Comprehensive Designation; Hiatt Named Deputy Director, NCI Cancer Control

This article is from The Cancer Letter archive.

Vol. 23 No. 42 | October 31, 1997

Download PDF Visit The Full Archive

Related Articles

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

December 17, 2013

In Brief: Biomedical Panel Report Will Support Cancer Program, Targeted Research

January 16, 1976

Final Issue Of Decade; Office Closed, But Not Phone Or Fax

December 15, 1989

Tobacco Council Lists 14 Smoking-Health Awards

July 30, 1976

Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development

March 15, 1991

NIH Panel Outlines Strategies To Manage Adrenal Tumors.

February 22, 2002